NVIDIA Corporation is a U.S.-based technology company specializing in accelerated computing. It designs and supplies graphics processing units (GPUs), data-center hardware, high‑speed networking, and a software ecosystem (including CUDA and AI libraries) used for artificial intelligence, high‑performance computing, simulation, and visualization across industries.
In the chemical and process sectors, NVIDIA’s platforms are applied to molecular dynamics and quantum chemistry workloads, materials discovery, computational fluid dynamics, and process optimization. Its hardware and software support AI-driven modeling, predictive maintenance, quality inspection, robotics, and digital‑twin simulations for plants and supply chains, helping researchers and operators run larger models, shorten iteration cycles, and scale data-intensive workflows from R&D through manufacturing.
None yet. When a new project in the record names NVIDIA as owner, partner or investor, it shows here.
Self-contained platform uses real-time digital twins and AI agents to interpret equipment data, reduce false alarms, predict asset health and simulate energy savings across existing systems.
Propylene‑glycol heat‑transfer fluids for direct liquid cooling; DC PG25 is NVIDIA DSX Ready Coolant; BASF cites backward integration for supply reliability and corrosion protection tech.
Founding-member move ties chemical R&D to a 45+ partner network using CuspAI’s MIRA platform for end-to-end generative‑AI materials discovery.
a wheeled humanoid robot was trialed in an electronics factory, autonomously moving totes, 60 moves/hour, >8h uptime, >90% pick success. Simulation-first AI cut prototype time from 18-24 to 7 months.
Roche expands its AI infrastructure with 2,176 NVIDIA GPUs, enhancing drug development, diagnostics, and manufacturing through advanced computing and AI integration.
The lab will invest $1B in AI to enhance drug discovery, integrating robotics and AI for continuous learning and improved medicine production.
The partnership aims to integrate AI into industrial processes, enhancing design, manufacturing, and supply chains, and developing AI-driven factories and operations.
The Polyphonic AI Fund supports AI-driven surgical innovations, awarding Mayo Clinic and QAS.AI for projects enhancing surgical precision and decision-making.
